Rising standards for tuberculosis drug development-Reference-Cited by-同舟云学术

Rising standards for tuberculosis drug development

Published:2008-11 Issue:11 Volume:29 Page:576-581
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Balganesh Tanjore S.,Alzari Pedro M.,Cole Stewart T.

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference54 articles.

1. Antibacterial natural products in medicinal chemistry – exodus or revival?;von Nussbaum;Angew. Chem. Int. Ed. Engl.,2006

2. Global epidemiology of tuberculosis;Dye;Lancet,2006

3. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project;Dye;J. Am. Med. Assoc.,1999

4. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic;Corbett;Arch. Intern. Med.,2003

5. Controlled clinical trial of four short course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. East African/British Medical Research Councils;Anon;Lancet,1974

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The quest to deliver high-dose rifampicin: can the inhaled approach help?;Expert Opinion on Drug Delivery;2024-01-02

2. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis;Progress in Biophysics and Molecular Biology;2023-07

3. Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular Mycobacterium tuberculosis;Microbiology Spectrum;2022-06-29

4. Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems;Antibiotics;2022-06-15

5. Chemical exploration of a highly selective scaffold with activity against intracellular Mycobacterium tuberculosis;2022-02-19